News
MF59 is used in Europe as an adjuvant in influenza vaccines. In fact, owing to its ability to increase the levels of functional hemagglutination inhibiting antibodies and CD8 + T-cell responses ...
It’s difficult to predict what this year’s flu season is going to be like. But it’s a good time to start thinking about ...
For example, Fluad Quad contains an adjuvant called MF59, an additional substance designed to attract immune cells to the site of vaccination. Other vaccines, such as Fluzone High-Dose ...
And last year, the HVTN 702 study of two co-administered HIV candidate vaccines from Sanofi Pasteur and GlaxoSmithKline, combined with GSK’s adjuvant MF59, was also discontinued due to a lack of ...
In 2021, for example, the HVTN702 study of two co-administered HIV candidate vaccines from Sanofi Pasteur and GSK, combined with GSK’s adjuvant MF59, was also discontinued due to a lack of efficacy.
Patients discontinuing adjuvant immunotherapy early due to toxicity do not have inferior outcomes compared to those completing 12 months of treatment. The study found a 2-year recurrence-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results